Y-Biologics, Inc Logo

Y-Biologics, Inc

Develops antibody-based therapeutics for cancer, focusing on immuno-oncology.

338840 | KO

Overview

Corporate Details

ISIN(s):
KR7338840002
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크로 4로 17, 비715호, 대전광역시

Description

Y-Biologics, Inc. is a biotechnology company specializing in the discovery and development of novel antibody-based therapeutics. The company's primary focus is on immuno-oncology, where it develops next-generation multispecific antibodies for the treatment of cancer. Y-Biologics leverages its proprietary human antibody discovery platform to advance its internal pipeline and support collaborations through technology transfers and joint development partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-09-10 00:00
임시주주총회결과
Korean 7.4 KB
2025-08-26 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean 12.4 KB
2025-08-26 00:00
주주총회소집공고
Korean 57.0 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-14 00:00
주식등의대량보유상황보고서(약식)
Korean 60.0 KB
2025-08-07 00:00
증권발행결과(자율공시) (제1회차 CB)
Korean 5.6 KB
2025-07-30 00:00
주요사항보고서(전환사채권발행결정)
Korean 107.3 KB
2025-07-30 00:00
주주총회소집결의 (임시주주총회)
Korean 7.1 KB
2025-07-30 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-07-15 00:00
투자판단관련주요경영사항 ([국책과제 선정] 글로벌 시장 진출형 다중항체의 품질 맞춤형 생산공정 기술 개발)
Korean 8.6 KB
2025-07-01 00:00
투자판단관련주요경영사항 ([국책과제 선정] 면역함암 항체의약품의 저항성 및 불응성 한계 극복을 위한 이중항체-사이토카인…
Korean 9.5 KB
2025-05-27 00:00
전환주식의전환청구권행사
Korean 15.3 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 970.8 KB
2025-05-13 00:00
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 항체 기술이전 계약 체결)
Korean 11.2 KB

Automate Your Workflow. Get a real-time feed of all Y-Biologics, Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Y-Biologics, Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Y-Biologics, Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.